期刊文献+

直肠腺癌肾上腺转移1例 被引量:1

下载PDF
导出
摘要 患者男性,53岁,2014年11月因无明显诱因出现间断性血便1年余,进行性加重入院,血便开始为鲜红色,后排出的血液中带有坏死物质或白色黏液样物质,1天2~3次,无明显腹痛,活动或劳累后加重。期间一直以“痔疮”反复就诊,使用“痔疮膏”等药物进行治疗效果不明显。入院后行结肠镜检查,提示直肠癌可能,活检病理检测报告直肠腺癌。后行腹部CT扫描发现左侧肾上腺区有一大小5.7 cm×3.2 cm软组织块影,密度欠均,似见点状稍高密度影,明显不均匀强化,部分肠管轻度受压,直肠下段局部管壁增厚,管腔狭窄,明显强化(图1),疑为直肠癌转移灶,遂行腹腔镜下直肠癌根治性切除术及开腹左侧肾上腺占位性病变切除术。术后临床分期T3N2M1,给予放、化疗为主的综合性治疗。术后至今多次入院行放、化疗,目前患者一般情况可,未发现明显的肿瘤复发或转移。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第5期623-624,共2页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献2

二级参考文献38

  • 1Hase K, Shatney C H, Johnson D, et al. Prognostic value of tumor "budding" in patients with colorectal cancer[J]. Dis Colon Rectum, 1993,36 ( 7 ) :627 - 35.
  • 2Ueno H, Murphy J, Jass J R, et al. Tumour ' budding' as an in- dex to estimate the potential of aggressiveness in rectal cancer[ J]. Histopathology, 2002,40 ( 2 ) : 127 - 32.
  • 3Wang L M, Kavens D, Mulcahy H, et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer[J]. Am J Surg Pathol, 2009,33( 1 ) :134 -41.
  • 4Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma[ J]. Dis Colon Rectum, 2002,45 (5) :628 - 34.
  • 5Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenoearci- noma[J]. J Surg Oncol, 2003,83( 1 ) :42 -7.
  • 6Prall F, Nizze H, Barten M. Tumour budding as prognostic factor in stage I / II colorectal carcinoma[ J]. Histopathology, 2005,47 (1) :17 -24.
  • 7Kazama S, Watanabe T, Ajioka Y, et al. Tumor budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2 [ J ]. Br J Cancer, 2006,94 (2) :293 - 8.
  • 8Ono M, Sakamoto M, Ino Y, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis [ J ]. Cancer, 1996,78 ( 6 ) : 1179 - 86.
  • 9Shiozaki H, Oka H, Inoue M, et al. Ecadherin mediated adhesion system in cancer cells [ J ]. Cancer, 1996,77 (8 Suppl) : 1605 - 13.
  • 10Masaki T, Goto A, Sugiyama M, et al. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the forma- tion of budding tumor cells in patients with TI colorectal carcinoma [J]. Cancer, 2001,92(10) :2539 -46.

共引文献5

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部